FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jörg Thomalla

Research Profile

Geographic Areas

Germany

Concepts & Ideas

Procedures

Chemicals & Drugs

Disorders

Activities & Behaviors

Community Networks

Objects

Community Health Centers

Co-author Network

Publications

TOP 3
U Mergenthaler; Jochen Heymanns; H Köppler; Jörg Thomalla; C van Roye; J Schenk; R Weide
Evaluation of psychosocial distress in patients treated in a community-based oncology group practice in Germany.
H Köppler; Jochen Heymanns; Jörg Thomalla; K Kleboth; Rudolf Weide
The impact of new treatment options for advanced colorectal cancer on routine care: results of a retrospective analysis of 206 consecutive patients treated in a community-based oncology group practice in Germany.
Rudolf Weide; Ulrike Mergenthaler; Vera Friesenhahn; Kristina Kleboth; Jochen Heymanns; Jörg Thomalla; Hubert Köppler
Bendamustine/mitoxantrone/rituximab: a short remission induction chemoimmunotherapy for elderly patients with relapsed or refractory chronic lymphocytic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jörg Thomalla (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: U Mergenthaler; Jochen Heymanns; H Köppler; Jörg Thomalla; C van Roye; J Schenk; R Weide
Evaluation of psychosocial distress in patients treated in a community-based oncology group practice in Germany.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(4):931-8.
2010: H Köppler; Jochen Heymanns; Jörg Thomalla; K Kleboth; Rudolf Weide
The impact of new treatment options for advanced colorectal cancer on routine care: results of a retrospective analysis of 206 consecutive patients treated in a community-based oncology group practice in Germany.
European journal of cancer care 2010;19(6):795-802.
2009: Rudolf Weide; Ulrike Mergenthaler; Vera Friesenhahn; Kristina Kleboth; Jochen Heymanns; Jörg Thomalla; Hubert Köppler
Bendamustine/mitoxantrone/rituximab: a short remission induction chemoimmunotherapy for elderly patients with relapsed or refractory chronic lymphocytic leukemia.
Leukemia & lymphoma 2009;50(9):1468-74.
2009: Rudolf Weide; Ulrike Mergenthaler; Annette Pandorf; Holger Arndt; Jochen Heymanns; Jörg Thomalla; Hubert Köppler
Improved survival of patients with metastatic breast cancer in routine care: results of a retrospective study in a community-based oncology group practice 1995-2005.
Onkologie 2009;32(3):107-13.
2009: Hubert Koeppler; Jochen Heymanns; Jörg Thomalla; Kristina Kleboth; Ulrike Mergenthaler; Rudolf Weide
Treatment of advanced non small cell lung cancer in routine care: a retrospective analysis of 212 consecutive patients treated in a community based oncology group practice.
Clinical medicine. Oncology 2009;3():63-70.
2007: Rudolf Weide; Margit Arndt; Annette Pandorf; Jochen Heymanns; Jörg Thomalla; Hubert Köppler
Ovarian cancer treatment reality in northern Rheinland-Pfalz (Germany). Suboptimal surgical treatment as a possible cause for inferior survival.
Onkologie 2007;30(12):611-7.
2007: Rudolf Weide; Georg Hess; Hubert Köppler; Jochen Heymanns; Jörg Thomalla; Ali Aldaoud; Christoph Losem; Stefan Schmitz; Ursula Haak; Christoph Huber; Michael Unterhalt; Wolfgang Hiddemann; Martin Dreyling
High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).
Leukemia & lymphoma 2007;48(7):1299-306.
2005: Rudolf Weide; Jochen Heymanns; Jörg Thomalla; Hubert Köppler
[Lymphomas: new therapeutic options].
MMW Fortschritte der Medizin 2005;147(24):28, 30-1.